OPPM
SURF

Opus Point Partners Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Opus Point Partners Management’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-53,063
Closed -$253K – 75
2019
Q1 		$253K Buy
+53,063
New +$261K 0.34% 68

Other funds holding SURF

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Opus Point Partners Management's SURF Position: Q2 2019 in Review

Opus Point Partners Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2019, closing a stake of 53,063 shares — an estimated $253K sold.

Opus Point Partners Management first reported a position in SURF in Q1 2019 and held it in 1 quarter. The position peaked at $253K in Q1 2019. 47 funds tracked by Wall St. Rank hold SURF as of Q2 2019.

  • Opus Point Partners Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Opus Point Partners Management sold 53,063 Surface Oncology, Inc. Common Stock shares in Q2 2019, an estimated $253K.
  • Opus Point Partners Management first reported a position in Surface Oncology, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Opus Point Partners Management's Surface Oncology, Inc. Common Stock position peaked at $253K in Q1 2019.
  • 47 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2019.

Based on Opus Point Partners Management's 13F filing for Q2 2019, filed 14 Aug 2019.